Hepatotoxicity potential of Saw Palmetto (Serenoa repens) in rats

Phytomedicine

Volumn 14, Issue 2-3, 2007, Pages 204-208

  Singh, Y N ^a   Devkota, A K ^a   Sneeden, D C ^a   Singh, K K ^a   Halaweish, F ^a  

^a SOUTH DAKOTA STATE UNIVERSITY   (United States)

Author keywords

Hepatotoxicity; Lipid peroxidation; Liver function tests; Saw palmetto; Serenoa repens

Indexed keywords

BIOLOGICAL MARKER; ENZYME; MALONALDEHYDE; PLACEBO; SABAL EXTRACT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD SAMPLING; BODY WEIGHT; CONTROLLED STUDY; DIAGNOSTIC KIT; DRUG SCREENING; ENZYME ACTIVITY; ENZYME ASSAY; HERB; HUMAN; LIPID PEROXIDATION; LIVER FUNCTION; LIVER TOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT; SABAL;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; FRUIT; HEPATITIS, TOXIC; LIPID PEROXIDATION; LIVER; MALE; MALONDIALDEHYDE; PHYTOTHERAPY; PLANT EXTRACTS; PROSTATIC HYPERPLASIA; RATS; RATS, SPRAGUE-DAWLEY; SERENOA;

ANIMALIA; RATTUS; SERENOA REPENS;

EID: 33846348366     PISSN: 09447113     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.phymed.2006.03.024     Document Type: Article

References (15)

1. Blumenthal M. Herbs continue to slide in mainstream market: sales down 14%. HerbalGram 58 (2003) 71
2. In: Blumenthal M., Busse W.R., Goldberg A., Gruenwald J., Hall T., Riggins C.W., Rister R.S., and Klein S. (Eds). The Complete German Commission E Monographs (1998), American Botanical Council, Austin, TX 201
3. Coleman C.I., Hebert J.H., and Reddy P. The effect of phytosterols on quality of life in the treatment of benign prostatic hyperplasia. Pharmacotherapy 22 (2002) 1426-1433
4. Dankoff J.S. Near fatal liver dysfunction secondary to administration of flutamide for prostate cancer. J. Urol. 148 (1992) 1914
5. Di Silverio F., D'Eramo G., Lubrano C., Flammia G.P., Sciarra A., Palma E., Caponera M., Mauro M., Buscarini M., and Tavani M. Evidence that Serenoa repens extract displays an antiestrogenic activity in prostatic tissue of benign prostatic hypertrophy patients. Eur. Urol. 45 (1992) 143-149
6. Haemmerli H.U. Jaundice during pregnancy. In: Schiff L. (Ed). Diseases of the Liver (1975), J.B. Lippincott, Philadelphia 1336-1348
7. Hamid S., Rojter S., and Vierling J. Protracted cholestatic hepatitis after the use of Prostata. Ann. Intern. Med. 127 (1997) 169-170
8. Jacobsen S.J., Girman C.J., Guess H.A., Oesterling J.E., and Lieber M.M. New diagnosis and treatment guidelines for benign prostatic hyperplasia. Arch. Intern. Med. 155 (1959) 477-481
9. Kottra L.L., and Kappas A. Effect of estradiol on plasma disappearance rate of sulfobromophthalein in man. Ann. Intern. Med. 117 (1966) 373-375
10. Lee V., Randhawa A.K., and Singal P.K. Adriamycin-induced myocardial dysfunction in vitro is mediated by free radicals. Am. J. Physiol. 261 Heart Circ. Physiol. 30 (1991) H989-H995
11. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193 (1951) 265-275
12. Marchetti B., and Labrie F. Characteristics of flutamide action on prostate and testicular functions in the rat. J. Steroid Biochem. 29 (1988) 691-698
13. MIDAS report, 1997. IMS Global services. Quoted in Wilt T.J., Ishani, A., Stark, G., McDonald, R., Lau, J, Mulrow, C., 1998. Saw palmetto extracts for treatment of benign prostatic hyperplasia. A systematic review. JAMA 280, 1604-1609.
14. Oesterling J.E. Benign prostatic hyperplasia. Medical and minimally invasive treatment options. New Eng. J. Med. 332 (1995) 99-109
15. Wilt T.J., Ishani A., Stark G., McDonald R., Lau J., and Mulrow C. Saw palmetto extracts for treatment of benign prostatic hyperplasia. A systematic review. JAMA 280 (1998) 1604-1609